Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSP Group Regulatory News (SSPG)

Share Price Information for SSP Group (SSPG)

Share Price is delayed by 15 minutes
Get Live Data
163.60    -2.90 (-1.74%)
Bid:
163.30
Ask:
163.90
Spread: 0.60 (0.367%)
Market Cap: £1.26b
SSPG Live PriceLast checked at - London Stock Exchange

Intraday SSP Group Share Chart

Director/PDMR Shareholding

5 Mar 2018 18:15

RNS Number : 7591G
SSP Group PLC
05 March 2018
 

FOR IMMEDIATE RELEASE LEI: 213800QGNIWTXFMENJ24

 

 

5 March 2018

SSP Group plc

(the "Company")

 

Notification of transaction by a Person Discharging Managerial Responsibility ("PDMR") in connection with the Vesting and Exercise of Awards under the Performance Share Plan ("PSP")

 

The Company today makes the following announcement regarding the vesting and exercise of the first PSP awards granted following the IPO in 2014 over ordinary shares of 1p in the capital of the Company (the "Shares") held by one of its PDMRs under the PSP (the "PSP Awards"). Full details of the PSP Awards are included in SSP's 2017 Annual Report:

 

Name of PDMR

Position

Number of Shares acquired on vesting/exercise of PSP Awards

Number of Shares sold on vesting/exercise of PSP Awards

Total number of Shares held following sale*

Mark Angela

Chief Commercial Officer and CEO - Eastern Europe and Middle East

194,935

 

 

93,710

 

834,584

 

*not including unvested/unexercised awards under the PSP. This does include issued Shares held in the Company's UK Share Incentive Plan.

 

The notification of dealing form for Mark Angela can be found below.

 

This announcement, including the notifications below, is made in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

 

 For further information, please contact:

 SSP Group plc

Helen Byrne, Company Secretary

Tel: +44 (0) 207 543 3404

 

 

 

1

Details of the person discharging managerial responsibility

a)

Name

Mark Angela

2

Reason for the notification

a)

Position/status

Chief Commercial Officer and CEO - Eastern Europe and Middle East

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

SSP Group plc

b)

Legal Entity Identifier Code

213800QGNIWTXFMENJ24

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 1 pence

b)

Identification Code

GB00BNGWY422

c)

Nature of the transaction

1. Exercise of an Award to acquire Shares under the Company's Performance Share Plan; and

2. Sale of Shares acquired on the exercise of an Award under the Company's Performance Share Plan

d)

Currency

GBP - British Pound

e)

Price(s) and Volume(s)

Exercise:

Price(s) per share

Volume(s)

Aggregate Price

£0

194,935

£0

Sale:

Price(s) per share

Volume(s)

Aggregate Price

£5.9385

93,710

£556,496.84

f)

Aggregated Information

- Price

- Volume

- Total Price

Exercise:

Price(s) per share

Volume(s)

Total Aggregate Price

£0

194,935

£0

 

Sale:

Price(s) per share

Volume(s)

Aggregate Price

£5.9385

93,710

£556,496.84

g)

Date of transaction

2 March 2018

h)

Place of transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEAPDSEEEPEFF
Date   Source Headline
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
20th Oct 20252:00 pmRNSHolding(s) in Company
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20258:00 amRNSAppointment of Joint Corporate Broker
9th Oct 20257:01 amRNSShare Buyback Programme
9th Oct 20257:00 amRNSQ4 Trading Update
7th Oct 202510:19 amRNSDirector/PDMR Shareholding
1st Oct 20255:13 pmRNSDirector/PDMR Shareholding
8th Sep 20255:24 pmRNSDirector/PDMR Shareholding
6th Aug 20255:48 pmRNSDirector/PDMR Shareholding
29th Jul 20257:00 amRNSQ3 Trading Update
14th Jul 20257:00 amRNSIPO of TFS - First Day of Trading
10th Jul 20259:53 amRNSTR1 Notification of major interest in shares
10th Jul 20259:17 amRNSFiling of Prospectus and Pricing of TFS IPO
8th Jul 20255:23 pmRNSDirector/PDMR Shareholding
7th Jul 202511:36 amRNSHolding(s) in Company
7th Jul 20257:00 amRNSOpening of TFS IPO Offer
2nd Jul 202512:01 pmRNSHolding(s) in Company
2nd Jul 20257:00 amRNSUpdate on Proposed TFS IPO
30th Jun 20257:00 amRNSTotal Voting Rights
27th Jun 20256:19 pmRNSHolding(s) in Company
9th Jun 20254:30 pmRNSDirector/PDMR Shareholding
6th Jun 20254:00 pmRNSBlock listing Interim Review
23rd May 202512:30 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNS2025 HALF YEAR RESULTS
15th May 20252:30 pmRNSDirector/PDMR Shareholding
30th Apr 20254:00 pmRNSHolding(s) in Company
15th Apr 20255:45 pmRNSDirector/PDMR Shareholding
8th Apr 20251:41 pmRNSDirector/PDMR Shareholding
7th Apr 20255:02 pmRNSDirector/PDMR Shareholding
1st Apr 20256:00 pmRNSHolding(s) in Company
1st Apr 20256:00 pmRNSHolding(s) in Company
31st Mar 20256:20 pmRNSHolding(s) in Company
7th Mar 202511:07 amRNSDirector/PDMR Shareholding
6th Mar 20254:23 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.